Armstrong RW Bolding F Joseph R Septic arthritis following arthroscopy: clinical syndromes and analysis of risk factors Arthroscopy 1992 8 213-31 
Charalambous CP Tryfonidis M Sadiq S Hirst P Paul A Septic arthritis following intra-articular steroid injection of the knee &#8212; a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee Clin Rheumatol 2003 22 386-90 
von Essen R Savolainen HA Bacterial infection following intra-articular injection &#8212; a brief review. Scan J Rheumatol 1989 18 7-12 
Kalteis T L&#252;ring C Schaumburger J Perlicl L B&#228;this H Grifka J Gewebetoxizit&#228;t lokaler Antiseptika. Z Orthop 2003 141 233-8 
Schaumburger J Beckmann J Springorum HR Handel M Anders S Kalteis T Toxitit&#228;t lokaler Antiseptika auf Chondrozyten in vitro Z Orthop Unfall 2010 148 39-43 
Riegels-Nielsen P Frimodt-M&#246;ller N Jensen J Rabbit model of septic arthritis Acta Orthop Scand 1987 58 14-9 
Ryan MJ Kavanagh R Wall PG Hazleman BL Bacterial joint infection in England and Wales: analysis of bacterial isolates over a four year period Br J Rheumatol 1997 36 370-3 
Smith M Arthroscopic treatment of the septic knee Arhtroscopy 1986 2 30-4 
Muir H The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules Bioessays 1995 17 1039-48 
Goldring MB The role of the chondrocytes in osteoarthritis Arthritis Rheum 2000 43 1916-26 
Newman AP Articular cartilage repair Am J Sports Med 1998 26 309-24 
de Crombrugghe B Lefebvre V Behringer RR Bi W Murakami S Huang W Transcriptional mechanisms of chondrocytes differentiation Matrix Biol 2000 9 389-94 
Goldring MB Update on the biology of the chondrocyte and new approaches to treating cartilage disease Best Pract Res Clin Rheumatol 2006 20 1003-25 
M&#252;ller G Kramer A Effect of selected wound antiseptics on adult articular cartilage (bovine sesamoid bone) in the presence of Escherichia coli and Staphylococcus aureus J Orth Res 2005 23 127-33 
Bates EJ Johnson CC Lowther DA Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage Biochimica Biophysica Acta 1984 838 221-8 
R&#246;hner E Detert J Kolar P Hocke A N&#8217;Guessan P Matziolis G Induced apoptosis of chondrocytes by Porphyromonas gingivalis as a possible pathway for cartilage loss in rheumatoid arthritis Cal Tiss Int 2010 87 333-40 
Pischon N R&#246;hner E Hocke A N&#8217;Guessan P M&#252;ller HC Matziolis G Effects of Porphyromonas gingivalis on cell cycle progression and apoptosis of primary human chondrocytes Ann Rheum Dis 2009 68 1902-7 
Stutz G G&#228;chter A Diagnostik und stadiengerechte Therapie von Gelenkinfekten Unfallchirurg 2001 104 682-6 
Ince A Sch&#252;tze N Hendrich C Jakob F Eulert J L&#246;hr JF Effect of polyhexanide and gentamicin on human osteoblasts and endothelial cells Swiss Med Wkly 2007 137 139-45 
Berg K Carmichael WW Skulberg OM Benestad C Underdal B Investigation of a toxic water-bloom of Microcystis aeruginosa (Cyanophyaceae) in Lake Akersvatn, Norway Hydrobiologia 1987 144 2 97-103 
Botha N Gehringer MM Downing TG Venter M Shephard EG The role of microcystin-LR in the induction of apoptosis and oxidative stress in Caco2 cells Toxicon 2004 43 85-92 
Burja AM Banaigs B Abou-Mansour E Burgess JG Wright PC Marine cyanobacteria&#8212;a prolific source of natural products Tetrahedron 2001 57 9347-9377 
Castenholz RW Garrity GM Cyanobacteria Bergey`s manual of systematic bacteriology. Volume 1, the Archaea and the deeply branching phototrophic Bacteria 2001 Berlin Heidelberg New York Springer 473-599 
Chang W McClain CJ Liu MC Barve SS Chen TS Effects of 2(rs)-n-propylthiazolidine-4(r)-carboxylic acid on 4-hydroxy-2-nonenal-induced apoptotic cell death J Nutr Biochem 2008 19 184-192 
Chorus I Falconer IR Salas HJ Bartram J Health risks caused by freshwater cyanobacteria in recreational waters J Toxicol Environ Health 2000 3 323-347 
Codd GA Lindsay J Young FM Morrison LF Metcalf JS Huisman J , Matthijs HCP , Visser PM Harmful cyanobacteria Harmful cyanobacteria 2005 Berlin Heidelberg New York Springer 1-23 
Cohen P Alemany S Hemmings BA Resink TJ Str&#229;lfors P Tung HY Protein phosphatase-1 and protein phosphatase-2a from rabbit skeletal muscle Methods Enzymol 1988 159 390-408 
Edvardsen B Skulberg R Skulberg OM NIVA Culture Collection of Algae&#8212;microalgae for science and technology Nova Hedwig Beih 2004 79 99-114 
Fischbach MA Walsh CT Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery and mechanisms Chem Rev 2006 106 3468-3496 
Fischer WJ Altheimer S Cattori V Meier PJ Dietrich DR Hagenbuch B Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin Toxicol Appl Pharmacol 2005 203 257-263 
Fladmark KE Brustugun OT Hovland R Boe R Gjertsen BT Zhivotovsky B Doskeland SO Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors Cell Death Differ 1999 6 1099-1108 
Fladmark KE Serres MH Larsen NL Yasumoto T Aune T Doskeland SO Sensitive detection of apoptogenic toxins in suspension cultures of rat and salmon hepatocytes Toxicon 1998 36 8 1101-1114 
Foulds LM Boysen RI Crane M Yang Y Muir JA Smith AI Kretser DM Hearn MT Hedger MP Molecular identification of lysoglycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids Biol Reprod 2008 79 525-536 
Gausdal G Gjertsen BT McCormack E Damme P Hovland R Krakstad C Bruserud O Gevaert K Vanderkerckhove J Doskeland SO Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death Blood 2008 111 2866-2877 
Gjertsen BT Cressey LI Ruchaud S Houge G Lanotte M Doskeland SO Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia) cell line J Cell Sci 1994 107 Pt 12 3363-3377 
Herfindal L Oftedal L Selheim F Wahlsten M Sivonen K Doskeland SO A high proportion of Baltic Sea benthic cyanobacterial isolates contain apoptogens able to induce rapid death of isolated rat hepatocytes Toxicon 2005 46 3 252-260 
Hoeger SJ Shaw G Hitzfeld BC Dietrich DR Occurrence and elimination of cyanobacterial toxins in two Australian drinking water treatment plants Toxicon 2004 43 639-649 
Jaspars M Lawton LA Cyanobacteria-a novel source of pharmaceuticals Curr Opin Drug Discov Devel 1998 1 77-84 
Jun DY Kim JS Park HS Song WS Bae YS Kim YH Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of Cdk4 and cyclin B1 in human Jurkat T cells Toxicol Appl Pharmacol 2007 222 190-201 
Lacaze N Gombaud-Saintonge G Lanotte M Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway &#8216;leukemic stem cell line&#8217; Leuk Res 1983 7 2 145-154 
Lu H Choudhuri S Ogura K Csanaky IL Lei XH Cheng XG Song PZ Klassen CD Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR Toxicol Sci 2008 103 35-45 
Mann J Natural products as immunosuppressive agents Nat Prod Rep 2001 18 417-430 
McCormack E Bruserud O Gjertsen BT Animal models of acute myelogenous leukaemia-development, application and future perspectives Leukemia 2005 19 687-706 
Mellgren G Vintermyr OK Doskeland SO Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: modulation of the cAMP effect by phosphatase inhibitors and nutrients J Cell Physiol 1995 162 2 232-240 
Newman DJ Cragg GM Marine natural products and related compounds in clinical and advanced preclinical trials J Nat Prod 2004 67 1216-1238 
Rasool M Sabina EP Appraisal of immunomodulatory potential of Spirula fusiformis: an in vivo and in vitro study Nat Med (Tokyo) 2009 63 169-175 
Sandal T Aumo L Hedin L Gjertsen BT Doskeland SO Irod/Ian5: an inhibitor of gamma-radiation and okadaic acid-induced apoptosis Mol Biol Cell 2003 14 3292-3304 
Seglen PO Prescott DM Preparation of isolated rat liver cells Methods in cell biology 1976 New York Academic Press 29-83 
Shen C Maerten P Geboes K Assche G Rutgeerts P Ceuppens JL Infliximab induces apoptosis of monocytes and T lymphocytes in human-mouse chimeric model Clin Immunol 2005 115 250-259 
Simmons TL Andrianasolo E McPhail K Flatt P Gerwick WH Marine natural products as anticancer drugs Mol Cancer Ther 2005 4 333-342 
Simo C Moreno-Arribas MV Cifuentes A Ion-trap versus time-of-flight mass spectrometry coupled to capillary electrophoresis to analyze biogenic amines in wine J Chromatogr A 2008 1195 1&#8211;2 150-156 
Sivonen K B&#246;rner T Herrero A , Flores E Bioactive compounds produced by cyanobacteria The cyanobacteria. Molecular biology, genomics and evolution 2008 Norfolk Caister Academic Press 159-197 
Sivonen K Jones G Chorus I , Bartram J Cyanobacterial toxins Toxic cyanobacteria in water. A guide to their public health consequences, monitoring and management 1999 London E &amp; FN Spon 41-111 
Skulberg OM Carmichael WW Andersen RA Matsunaga S Moore RE Skulberg R Investigation of a neurotoxic Oscillatoriales strain (Cyanophyceae) and its toxin. Isolation and characterization of homoanatoxin-a Environ Toxicol Chem 1992 11 321-329 
Tan LT Bioactive natural products from marine cyanobacteria for drug discovery Phytochemistry 2007 68 958-979 
Rockstroh JK Mocroft A Soriano V Tural C Losso MH Horban A Kirk O Phillips A Ledergerber B Lundgren J Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy J Infect Dis 2005 192 992-1002 
Abdala N Carney JM Durante AJ Klimov N Ostrovski D Somlai AM Kozlov A Heimer R Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia Int J STD AIDS 2003 14 697-703 
Thomas DL Vlahov D Solomon L Cohn S Taylor E Garfein R Nelson KE Correlates of hepatitis C virus infections among injection drug users in Baltimore Medicine 1995 74 212-220 
Lincoln D Petoumenos K Dore GJ HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy HIV Med 2003 4 241-249 
Solomon SS SriKrishnan AK Mehta SH Vasudevan CK Murugavel KG Thamburaj E Anand S Kumar MS Latkin C Solomon S Celentano DD High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern J Acquir Immune Defic Syndr 2008 49 327-332 
Quan VM Go VF Nam LV Bergenstrom A Thuoc NP Zenilman J Latkin C Celentano DD Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study AIDS Care 2009 21 7-16 
Tan Y Wei QH Chen LJ Chan PC Lai WS He ML Kung HF Lee SS Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China PLoS ONE 2008 3 e3608 
Garten RJ Lai S Zhang J Liu W Chen J Vlahov D Yu XF Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China Int J Epidemiol 2004 33 182-188 
McGovern BH Wurcel A Kim AY Schulze zur WJ Bica I Zaman MT Timm J Walker BD Lauer GM Acute hepatitis C virus infection in incarcerated injection drug users Clin Infect Dis 2006 42 1663-1670 
Holsen DS Harthug S Myrmel H Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway Eur J Clin Microbiol Infect Dis 1993 12 673-676 
Sulkowski MS Thomas DL Hepatitis C in the HIV-infected patient Clin Liver Dis 2003 7 179-194 
Danta M Brown D Bhagani S Pybus OG Sabin CA Nelson M Fisher M Johnson AM Dusheiko GM Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours AIDS 2007 21 983-991 
Fierer DS Uriel AJ Carriero DC Klepper A Dieterich DT Mullen MP Thung SN Fiel MI Branch AD Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study J Infect Dis 2008 198 683-686 
van de Laar T Pybus O Bruisten S Brown D Nelson M Bhagani S Vogel M Baumgarten A Chaix ML Fisher M Gotz H Matthews GV Neifer S White P Rawlinson W Pol S Rockstroh J Coutinho R Dore GJ Dusheiko GM Danta M Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men Gastroenterology 2009 136 1609-1617 
Gerberding JL Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study J Infect Dis 1994 170 1410-1417 
Goedert JJ Chen BE Preiss L Aledort LM Rosenberg PS Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940-1990 Am J Epidemiol 2007 
Ticehurst JR Hamzeh FM Thomas DL Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis J Clin Microbiol 2007 45 2426-2433 
Mellors JW Rinaldo CRJ Gupta P White RM Todd JA Kingsley LA Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 1996 272 1167-1170 
Drucker E Alcabes PG Marx PA The injection century: massive unsterile injections and the emergence of human pathogens Lancet 2001 358 1989-1992 
Magiorkinis G Magiorkinis E Paraskevis D Ho SY Shapiro B Pybus OG Allain JP Hatzakis A The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis PLoS Med 2009 6 e1000198 
Frank C Mohamed MK Strickland GT Lavanchy D Arthur RR Magder LS El Khoby T Abdel-Wahab Y Aly Ohn ES Anwar W Sallam I The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt Lancet 2000 355 887-891 
Garfein RS Doherty MC Monterroso ER Thomas DL Nelson KE Vlahov D Prevalence and incidence of hepatitis C virus infection among young adult injection drug users J Acquir Immune Defic Syndr Hum Retrovirol 1998 18 Suppl 1 S11-S19 
Quinn TC Groseclose SL Spence M Provost V Hook EW III Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience J Infect Dis 1992 165 541-544 
Kelen GD Green GB Purcell RH Chan DW Qaqish BF Sivertson KT Quinn TC Hepatitis B and hepatitis C in emergency department patients N Engl J Med 1992 326 1399-1404 
Thomas DL Astemborski J Rai RM Anania FA Schaeffer M Galai N Nolt K Nelson KE Strathdee SA Johnson L Laeyendecker O Boitnott J Wilson LE Vlahov D The natural history of hepatitis C virus infection: host, viral, and environmental factors JAMA 2000 284 450-456 
Thomas DL Astemborski J Vlahov D Strathdee SA Ray SC Nelson KE Galai N Nolt KR Laeyendecker O Todd JA Determinants of the quantity of hepatitis C virus RNA J Infect Dis 2000 181 844-851 
Torriani FJ Rodriguez-Torres M Rockstroh JK Lissen E Gonzalez-Garcia J Lazzarin A Carosi G Sasadeusz J Katlama C Montaner J Sette H Passe S De Pamphilis J Duff F Schrenk UM Dieterich DT Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 2004 351 438-450 
Hadziyannis SJ Sette H Morgan TR Balan V Diago M Marcellin P Ramadori G Bodenheimer H Bernstein D Rizzetto M Zeuzem S Pockros PJ Lin A Ackrill AM Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 2004 140 346-355 
Graham CS Baden LR Yu E Mrus JM Carnie J Heeren T Koziel MJ Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis Clin Infect Dis 2001 33 562-569 
Goedert JJ Eyster ME Lederman MM Mandalaki T De Moerloose P White GC Angiolillo AL Luban NL Sherman KE Manco-Johnson M Preiss L Leissinger C Kessler CM Cohen AR DiMichele D Hilgartner MW Aledort LM Kroner BL Rosenberg PS Hatzakis A End-stage liver disease in persons with hemophilia and transfusion- associated infections Blood 2002 100 1584-1589 
Chung RT Evans SR Yang Y Theodore D Valdez H Clark R Shikuma C Nevin T Sherman KE AIDS Clinical Trials Groups 383 Study Team Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects AIDS 2002 16 1915-1923 
Lohse N Hansen AB Pedersen G Kronborg G Gerstoft J Sorensen HT Vaeth M Obel N Survival of persons with and without HIV infection in Denmark, 1995-2005 Ann Intern Med 2007 146 87-95 
Weber R Sabin CA Friis-Moller N Reiss P El Sadr WM Kirk O Dabis F Law MG Pradier C De Wit S Akerlund B Calvo G Monforte A Rickenbach M Ledergerber B Phillips AN Lundgren JD Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study Arch Intern Med 2006 166 1632-1641 
Bica I McGovern B Dhar R Stone D McGowan K Scheib R Snydman DR Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection Clin Infect Dis 2001 32 492-497 
Janke EA McGraw S Garcia-Tsao G Fraenkel L Psychosocial issues in hepatitis C: a qualitative analysis Psychosomatics 2008 49 494-501 
Marcellin F Preau M Ravaux I Dellamonica P Spire B Carrieri MP Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research HIV Clin Trials 2007 8 320-327 
Mahoney FJ Stewart K Hu HX Coleman P Alter MJ Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States Arch Intern Med 1997 157 2601-2605 
Rockstroh JK Bhagani S Benhamou Y Bruno R Mauss S Peters L Puoti M Soriano V Tural C Europeans AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults HIV Med 2008 9 82-88 
Ghany MG Strader DB Thomas DL Seeff LB Diagnosis, management, and treatment of hepatitis C: An update Hepatology 2009 49 4 1335-1374 
Centers for Disease Control and Prevention Guidelines for Preventing Opportunistic Infections in HIV-Infected Adults and Adolescents - Recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America MMWR 2009 58 1-206 
Zhou J Dore GJ Zhang F Lim PL Chen YM Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database J Gastroenterol Hepatol 2007 22 1510-1518 
Lee SR Yearwood GD Guillon GB Kurtz LA Fischl M Friel T Berne CA Kardos KW Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection J Clin Virol 2010 48 15-17 
Soriano V Maida I Nunez M Garcia-Samaniego J Barreiro P Martin-Carbonero L Gonzalez-Lahoz J Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies Antivir Ther 2004 9 987-992 
Berenguer J Alvarez-Pellicer J Martin PM Lopez-Aldeguer J Von-Wichmann MA Quereda C Mallolas J Sanz J Tural C Bellon JM Gonzalez-Garcia J Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus Hepatology 2009 50 407-413 
McHutchison JG Everson GT Gordon SC Jacobson IM Sulkowski M Kauffman R McNair L Alam J Muir AJ Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection N Engl J Med 2009 360 1827-1838 
Villano SA Vlahov D Nelson KE Lyles CM Cohn S Thomas DL Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland J Clin Microbiol 1997 35 3274-7 
Thomas DL Curing hepatitis C with pills: a step toward global control Lancet 2010 376 1441-2 
Scott M.P. Trucksess W.M. Application of immunoaffinity columns to mycotoxin analysis J. AOAC Intl 1997 80 941-955 
Evaluation of certain Mycotoxins: Ochratoxin A, WHO Food Additives Series 47/FAO Food Nutrition Paper 2001 74 
Valenta H. Chromatographic methods for the determination of ochratoxin A in animal and human tissues and fluids J. Chromatogr. A 1998 815 75-92 
Monaci L. Palmisano F. Ochratoxin A determination in paired kidneys and muscle samples from swines slaughtered in southern Italy Anal. Bioanal. Chem. 2004 378 86-71 
Hancock J.R. D&#8217;agostino P.A. Mass spectrometric identification of toxins of biological origin Anal. Chim. Acta 2002 457 71-76 
Losito I. Monaci L. Palmisano F. Tantillo G. Determination of ochratoxin A in meat products by high-performance liquid chromatography coupled to electrospray ionisation sequential mass spectrometry Rapid Commun. Mass Spectrom 2004 18 1-7 
De Saeger D. Dumoulin F. Van Peterghem C. Quantitative determination of ochratoxin A in kidneys by liquid chromatography/mass spectrometry Rapid Commun. Mass Spectrom 2004 18 2661-2669 
Xiao H. Marquardt R.R. Abramson D. Frohlich A.A. Metabolites of ochratoxins in rat urine Appl. Envir. Microbiol 1996 62 648-655 
Biselli S. Hartig L. Wegener H. Analysis of. Fusarium Toxins using LC/MS&#8211;MS.:25&#8211;30 C. LC-GC, Eur. 2004 17 25-30 
Becker M. Degelman P. Herderich M. Schreier P. Humpf H.U. Determination of ochratoxin A at part-per-trillion level in Italian salami by immunoaffinity clean-up and high-performance liquid chromatography with fluorescence detection J. Chromatogr. A 1998 818 260-280 
Reinsch M. T&#246;pfer A. Lehmann A. Nehls I. Ochratoxin A, wine, tandem mass spectrometry, solid-phase extraction, anion exchange, liquid chromatography Anal. Bional. Chem. 2005 381 1592-1595 
Solfrizzo M. Avantaggiato G. Visconti A. Use of various clean-up procedures for the analysis of ochratoxin A in cereals J. Chromatr. A 1998 815 67-73 
Chaturvedi P. Smith T. Zabe T.N. Kohn B.A. A new method for simultaneous aflatoxin and ochratoxin clean-up for HPLC analysis in grains Inst. Food Technol. Ann. Mtg. 1999 Chicago IFT 234 Chicago Abstracts
Menezes M.L. F&#233;lix G. On line extraction and separation of bendiocarb, methomyl, methylparathion and pentachlorophenol pesticides from raw milk J. Liq. Chromatogr. 1998 21 2863-2871 
Derlet R. W. Overcrowding in emergency departments: Increased demand and decreased capacity Ann. Emerg. Med 2002 39 4 430-432 
Fatovich D. M. Nagree Y. Sprivulis P. Access block causes emergency department overcrowding and ambulance diversion in Perth, Western Australia Emerg. Med. J 2005 22 5 351-354 
Twanmoh J. R. Cunningham G. P. When overcrowding paralyzes an emergency department Manag. Care 2006 15 6 54-59 
Ackermann R. J. Kemle K. A. Vogel R. L. Griffin R. C. Jr Emergency department use by nursing home residents Ann. Emerg. Med 1998 31 6 749-757 
Asplin B. R. Magid D. J. Rhodes K. V. Solberg L. I. Lurie N. Camargo C. A. Jr A conceptual model of emergency department crowding Ann. Emerg. Med 2003 42 2 173-180 
Derlet R. W. Richards J. R. Overcrowding in the nation's emergency departments: complex causes and disturbing effects Ann. Emerg. Med 2000 35 1 63-68 
Derlet R. W. Richards J. R. Kravitz R. L. Frequent overcrowding in U.S. emergency departments Acad. Emerg. Med 2001 8 2 151-155 
Schull M. J. Morrison L. J. Vermeulen M. Redelmeier D. A. Emergency department gridlock and out-of-hospital delays for cardiac patients Acad. Emerg. Med 2003 10 7 709-716 
Schull M. J. Morrison L. J. Vermeulen M. Redelmeier D. A. Emergency department overcrowding and ambulance transport delays for patients with chest pain CMAJ 2003 168 3 277-283 
Liu S. Hobgood C. Brice J. H. Impact of critical bed status on emergency department patient flow and overcrowding Acad. Emerg. Med 2003 10 4 382-385 
Schull M. J. Vermeulen M. Slaughter G. Morrison L. Daly P. Emergency department crowding and thrombolysis delays in acute myocardial infarction Ann. Emerg. Med 2004 44 6 577-585 
Chen E. H. Mills A. M. Lee B. Y. Robey J. L. Zogby K. E. Shofer F. S. Reilly P. M. Hollander J. E. The impact of a concurrent trauma alert evaluation on time to head computed tomography in patients with suspected stroke Acad. Emerg. Med 2006 13 3 349-352 
Weiss S. J. Ernst A. A. Derlet R. King R. Bair A. E. Nick T. G. Relationship between the National ED Overcrowding Scale and the number of patients who leave without being seen in an academic ED Am. J. Emerg. Med 2005 23 3 288-294 
Rowe B. H. Channan P. Bullard M. Blitz S. Saunders L. D. Rosychuk R. J. Lari H. Craig W. R. Holroyd B. R. Characteristics of patients who leave emergency departments without being seen Acad. Emerg. Med 2006 13 8 848-852 
Hoot N. R. Zhou C. Jones I. Aronsky D. Measuring and forecasting emergency department crowding in real time Ann. Emerg. Med 2007 49 6 747-755 
Vieth T. L. Rhodes K. V. The effect of crowding on access and quality in an academic ED Am. J. Emerg. Med 2006 24 7 787-794 
Hoot N. R. Aronsky D. Systematic review of emergency department crowding: causes, effects, and solutions Ann. Emerg. Med 2008 52 2 126-136 
Baker D. W. Stevens C. D. Brook R. H. Patients who leave a public hospital emergency department without being seen by a physician. Causes and consequences JAMA 1991 266 8 1085-1090 
Asaro P. V. Lewis L. M. Boxerman S. B. Emergency department overcrowding: analysis of the factors of renege rate Acad. Emerg. Med 2007 14 2 157-162 
Hobbs D. Kunzman S. C. Tandberg D. Sklar D. Hospital factors associated with emergency center patients leaving without being seen Am. J. Emerg. Med 2000 18 7 767-772 
Schneider S. Zwemer F. Doniger A. Dick R. Czapranski T. Davis E. Rochester, New York: a decade of emergency department overcrowding Acad. Emerg. Med 2001 8 11 1044-1050 
Richardson P. An introduction to system dynamics modeling 1981 New York Productivity 
Banks J. Carson J. S. Nelson B. L. Nicol D. M. Discrete-event system simulation 2002 3 New Jersey Prentice-Hall 
Weiss S. J. Derlet R. Arndahl J. Ernst A. A. Richards J. Fern&#225;ndez-Frackelton M. Schwab R. Stair T. O. Vicellio P. Levy D. Brautigan M. Johnson A. Nick T. G. Estimating the degree of emergency department overcrowding in academic medical centers: results of the National ED Overcrowding Study (NEDOCS) Acad. Emerg. Med 2004 11 1 38-50 
Schlesinger S. Crosbie R. E. Innis G. S. Lalwani C. S. Loch J. Sylvester R. J. Wright R. O. Kheir N. Bartos D. Terminology for model credibility Simulation 1979 32 3 103-104 
Law A. M. Simulation modeling and analysis 2007 4 Boston McGraw-Hill 
Shechter S. M. Schaefer A. J. Braithwaite R. S. Roberts M. S. Increasing the efficient of monte carlo cohort simulation with variance reduction techniques Med. Decis. Mak 2006 26 550-553 
Reeder T. J. Garrison H. G. When the safety net is unsafe: real-time assessment of the overcrowded emergency department Acad. Emerg. Med 2001 8 11 1070-1074 
Reeder T. J. Burleson D. L. Garrison H. G. The overcrowded emergency department: a comparison of staff perceptions Acad. Emerg. Med 2003 10 10 1059-1064 
Bernstein S. L. Verghese V. Leung W. Lunney A. T. Perez I. Development and validation of a new index to measure emergency department crowding Acad. Emerg. Med 2003 10 9 938-942 
Asplin B. R. Rhodes K. V. Crain L. Camargo C. A. Measuring emergency department crowding and hospital capacity Acad. Emerg. Med 2002 9 5 366-367 
Asplin B. R. Rhodes K. V. Flottemesch T. J. Wears R. Camargo C. A. Jr Hwang U. Richards C. R. Tiffany B. O&#8217;Keefe S. Bernstein S. Is this emergency department crowded? A multicenter derivation and evaluation of an emergency department crowding scale (EDCS) Acad. Emerg. Med 2004 11 484 
Epstein S. K. Tian L. Development of an emergency department work score to predict ambulance diversion Acad. Emerg. Med 2006 13 4 421-426 
Jones S. S. Allen T. L. Flottemesch T. J. Welch S. J. An independent evaluation of four quantitative emergency department crowding scales Acad. Emerg. Med 2006 13 11 1204-1011 
Weiss S. J. Ernst A. A. Nick T. G. Comparison of the National Emergency Department Overcrowding Scale and the Emergency Department Work Index for quantifying emergency department crowding Acad. Emerg. Med 2006 13 5 513-518 
Chan T. C. Killeen J. P. Kelly D. Guss D. A. Impact of rapid entry and accelerated care at triage on reducing emergency department patient wait times, lengths of stay, and rate of left without being seen Ann. Emerg. Med 2005 46 6 491-497 
Arav-Boger R Foster CB Zong JC Pass RF Human cytomegalovirus-encoded &#945;-chemokines exhibit high sequence variability in congenitally infected newborns J Infect Dis 2006 193 788-791 
Arav-Boger R Zong JC Foster CB Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes Virus Genes 2005 31 65-72 
Baggiolini M Dewald B Moser B Human chemokines: An update Annu Rev Immunol 1997 15 675-705 
Beyari MM Hodgson TA Kondowe W Molyneux EM Scully C Porter SR Teo CG Inter-and intra-person cytomegalovirus infection in Malawian families J Med Virol 2005 75 575-582 
Cha TA Tom E Kemble GW Duke GM Mocarski ES Spaete RR Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains J Virol 1996 70 78-83 
Clark-Lewis I Schumacher C Baggiolini M Moser B Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities J Biol Chem 1991 266 23128-23134 
Davison AJ Dolan A Akter P Addison C Dargan DJ Alcendor DJ McGeoch DJ Hayward GS The human cytomegalovirus genome revisited: Comparison with the chimpanzee cytomegalovirus genome J Gen Virol 2003 84 17-28 
Dedicoat M Newton R Alkharsah KR Sheldon J Szabados I Ndlovu B Page T Casabonne D Gilks CF Cassol SA Whitby D Schulz TF Mother-to-child transmission of human herpesvirus-8 in South Africa J Infect Dis 2004 190 1068-1075 
Dolan A Cunningham C Hector RD Hassan-Walker AF Lee L Addison C Dargan DJ McGeoch DJ Gatherer D Emery VC Griffiths PD Sinzger C McSharry BP Wilkinson GW Davison AJ Genetic content of wild-type human cytomegalovirus J Gen Virol 2004 85 1301-1312 
Hassan-Walker AF Okwuadi S Lee L Griffiths PD Emery VC Sequence variability of the &#945;-chemokine UL146 from clinical strains of human cytomegalovirus J Med Virol 2004 74 573-579 
He R Ruan Q Qi Y Ma YP Huang YJ Sun ZR Ji YH Sequence variability of human cytomegalovirus UL146 and UL147 genes in low-passage clinical isolates Intervirology 2006 49 215-223 
Iwasenko JM Scott GM Ziegler J Rawlinson WD Emergence and persistence of multiple antiviral resistant CMV strains in a highly immunocompromised child J Clin Virol 2007 40 152-155 
Kall L Krogh A Sonnhammer EL A combined transmembrane topology and signal peptide prediction method J Mol Biol 2004 338 1027-1036 
Katoh K Kuma K Toh H Miyata T MAFFT version 5: Improvement in accuracy of multiple sequence alignment Nucleic Acids Res 2005 33 511-518 
Lurain NS Fox AM Lichy HM Bhorade SM Ware CF Huang DD Kwan SP Garrity ER Chou S Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts Virol J 2006 3 4 
Mattick C Dewin D Polley S Sevilla-Reyes E Pignatelli S Rawlinson W Wilkinson G Dal Monte P Gompels UA Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection J Virol 2004 318 582-597 
McGeoch DJ Rixon FJ Davison AJ Topics in herpesvirus genomics and evolution Virus Res 2006 117 90-104 
Murphy E Yu D Grimwood J Schmutz J Dickson M Jarvis MA Hahn G Nelson JA Myers RM Shenk TE Coding potential of laboratory and clinical strains of human cytomegalovirus Proc Natl Acad Sci USA 2003 100 14976-14981 
Penfold ME Dairaghi DJ Duke GM Saederup N Mocarski ES Kemble GW Schall TJ Cytomegalovirus encodes a potent &#945; chemokine Proc Natl Acad Sci USA 1999 96 9839-9844 
Pignatelli S Dal Monte P Landini MP gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes J Gen Virol 2001 82 2777-2784 
Pignatelli S Dal Monte P Rossini G Chou S Gojobori T Hanada K Guo JJ Rawlinson W Britt W Mach M Landini MP Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: Identification of a novel subgroup, geographical distribution and evidence of positive selective pressure J Gen Virol 2003 84 647-655 
Pignatelli S Dal Monte P Rossini G Landini MP Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains Rev Med Virol 2004 14 383-410 
Poncet C Frances V Gristina R Scheiner C Pellissier JF Figarella-Branger D CD24, a glyosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors Acta Neuropathol 1996 91 400-408 
Prichard MN Penfold MET Duke GM Spaete RR Kemble GW A review of genetic differences between limited and extensively passaged human cytomegalovirus strains Rev Med Virol 2001 11 191-200 
Pride DT 2004 Swaap 1.0.1: A tool for analyzing substitutions and similarity in multiple alignments.
Puchhammer-St&#246;ckl E G&#246;rzer I Cytomegalovirus and Epstein-Barr virus subtypes&#8212;The search for clinical significance J Clin Virol 2006 36 239-248 
Puchhammer-St&#246;ckl E G&#246;rzer I Zoufaly A Jaksch P Bauer CC Klepetko W Popow-Kraupp T Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients Transplantation 2006 81 187-194 
Qi Y Mao ZQ Ruan Q He R Ma YP Sun ZR Ji YH Huang Y Human cytomegalovirus (HCMV) UL139 open reading frame: Sequence variants are clustered into three major genotypes J Med Virol 2006 78 517-522 
Rasmussen L Geissler A Cowan C Chase A Winters M The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates J Virol 2002 76 10841-10848 
Rasmussen L Geissler A Winters M Inter-and intragenic variations complicate molecular epidemiology of human cytomegalovirus J Infect Dis 2003 187 809-819 
Rozas J S&#225;nchez-DelBarrio JC Messeguer X Rozas R DnaSP, DNA polymorphism analyses by the coalescent and other methods Bioinformatics 2003 19 2496-2497 
Schabath H Runz S Joumaa S Altevogt P CD24 affects CXCR4 function in pre-B lymphoytes and breast carcinoma cells J Cell Sci 2006 119 314-325 
Smith SC Oxford G Wu Z Nitz MD Conaway M Frierson HF Hampton G Theodorescu D The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer Cancer Res 2006 66 1917-1922 
Staden R Beal KF Bonfield JK The Staden package, 1998 Methods Mol Biol 2000 132 115-130 
Stanton R Westmoreland D Fox JD Davison AJ Wilkinson GW Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients J Med Virol 2005 75 42-46 
Tamura K Dudley J Nei M Kumar S MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0 Mol Biol Evol 2007 24 1596-1599 
Thompson JD Higgins DG Gibson TJ CLUSTAL W: Improving the sensitivity of progressive multiple sequencing alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res 1994 22 4673-4680 
Agulleiro MJ Roy S Sanchez E Puchol S Gallo-Payet N Cerda-Reverter JM Role of melanocortin receptor accessory proteins in the function of zebrafish melanocortin receptor type 2 Molecular and Cellular Endocrinology 320 2010 145-152 doi:10.1016/j.mce.2010.01.032 
Chan LF Webb TR Chung TT Meimaridou E Cooray SN Guasti L Chapple JP Egertova M Elphick MR Cheetham ME MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family PNAS 106 2009 6146-6151 doi:10.1073/pnas.0809918106 
Chan LF Metherell LA Clark AJ Effects of melanocortins on adrenal gland physiology European Journal of Pharmacology 2011 (In Press) doi:10.1016/j.ejphar.2010.11.041 
Clark AJ Weber A Adrenocorticotropin insensitivity syndromes Endocrine Reviews 19 1998 828-843 doi:10.1210/er.19.6.828 
Coll AP Challis BG Yeo GS Snell K Piper SJ Halsall D Thresher RR O'Rahilly S The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin Endocrinology 145 2004 4721-4727 doi:10.1210/en.2004-0491 
Cooray SN Almiro Do Vale I Leung KY Webb TR Chapple JP Egertova M Cheetham ME Elphick MR Clark AJ The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse Y1 cell line Endocrinology 149 2008 1935-1941 doi:10.1210/en.2007-1463 
Guasti L Paul A Laufer E King P Localization of Sonic hedgehog secreting and receiving cells in the developing and adult rat adrenal cortex Molecular and Cellular Endocrinology 336 2010 117-122 doi:10.1016/j.mce.2010.11.010 
Karpac J Ostwald D Bui S Hunnewell P Shankar M Hochgeschwender U Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice Endocrinology 146 2005 2555-2562 doi:10.1210/en.2004-1290 
Karpac J Kern A Hochgeschwender U Pro-opiomelanocortin peptides and the adrenal gland Molecular and Cellular Endocrinology 265&#8211;266 2007 29-33 doi:10.1016/j.mce.2006.12.035 
Lefkowitz RJ Roth J Pricer W Pastan I ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase PNAS 65 1970 745-752 doi:10.1073/pnas.65.3.745 
Lehoux JG Fleury A Ducharme L The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo Endocrinology 139 1998 3913-3922 doi:10.1210/en.139.9.3913 
Metherell LA Chapple JP Cooray S David A Becker C Ruschendorf F Naville D Begeot M Khoo B Nurnberg P Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2 Nature Genetics 37 2005 166-170 doi:10.1038/ng1501 
Mitani F Mukai K Miyamoto H Suematsu M Ishimura Y The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex Biochimica et Biophysica Acta 1619 2003 317-324 doi:10.1016/S0304-4165(02)00490-7 
Robinson PM Comline RS Fowden AL Silver M Adrenal cortex of fetal lamb: changes after hypophysectomy and effects of Synacthen on cytoarchitecture and secretory activity Quarterly Journal of Experimental Physiology 68 1983 15-27 
Roy S Rached M Gallo-Payet N Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells Molecular Endocrinology 21 2007 1656-1669 doi:10.1210/me.2007-0041 
Sebag JA Hinkle PM Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers PNAS 104 2007 20244-20249 doi:10.1073/pnas.0708916105 
Sebag JA Hinkle PM Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling Journal of Biological Chemistry 284 2009 610-618 doi:10.1074/jbc.M804413200 
Sebag JA Hinkle PM Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2 Science Signaling 3 2010 ra28 doi:10.1126/scisignal.2000593 
Wright N Voncina D Studies on the postnatal growth of the rat adrenal cortex Journal of Anatomy 123 1977 147-156 
Warburg O On the origin of cancer cells Science 1956 123 309-314 
Frezza C Gottlieb E Mitochondria in cancer: not just innocent bystanders Semin Cancer Biol 2009 19 4-11 
Tennant DA Duran RV Gottlieb E Targeting metabolic transformation for cancer therapy Nat Rev Cancer 2010 10 267-277 
Kaelin WG Jr SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling Cancer Cell 2009 16 180-182 
Frezza C Tennant DA Gottlieb E IDH1 mutations in gliomas: when an enzyme loses its grip Cancer Cell 2010 17 7-9 
Baysal BE Ferrell RE Willett-Brozick JE Lawrence EC Myssiorek D Bosch A Mey A Taschner PE Rubinstein WS Myers EN Richard CW 3rd Cornelisse CJ Devilee P Devlin B Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science 2000 287 848-851 
Niemann S Muller U Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nat Genet 2000 26 268-270 
Astuti D Latif F Dallol A Dahia PL Douglas F George E Skoldberg F Husebye ES Eng C Maher ER Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am J Hum Genet 2001 69 49-54 
Hao HX Khalimonchuk O Schraders M Dephoure N Bayley JP Kunst H Devilee P Cremers CW Schiffman JD Bentz BG Gygi SP Winge DR Kremer H Rutter J SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma Science 2009 325 1139-1142 
Bayley JP Kunst HP Cascon A Sampietro ML Gaal J Korpershoek E Hinojar-Gutierrez A Timmers HJ Hoefsloot LH Hermsen MA Suarez C Hussain AK Vriends AH Hes FJ Jansen JC Tops CM Corssmit EP Knijff P Lenders JW Cremers CW Devilee P Dinjens WN Krijger RR Robledo M SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma Lancet Oncol 2010 11 366-372 
Burnichon N Briere JJ Libe R Vescovo L Riviere J Tissier F Jouanno E Jeunemaitre X Benit P Tzagoloff A Rustin P Bertherat J Favier J Gimenez-Roqueplo AP SDHA is a tumor suppressor gene causing paraganglioma Hum Mol Genet 2010 19 3011-3020 
Housley SL Lindsay RS Young B McConachie M Mechan D Baty D Christie L Rahilly M Qureshi K Fleming S Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene Histopathology 2010 56 405-408 
Ricketts C Woodward ER Killick P Morris MR Astuti D Latif F Maher ER Germline SDHB mutations and familial renal cell carcinoma J Natl Cancer Inst 2008 100 1260-1262 
Henderson A Douglas F Perros P Morgan C Maher ER SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis Fam Can 2009 8 257-260 
Gottlieb E Tomlinson IP Mitochondrial tumour suppressors: a genetic and biochemical update Nat Rev Cancer 2005 5 857-866 
Nederveen FH Korpershoek E Lenders JW Krijger RR Dinjens WN Somatic SDHB mutation in an extraadrenal pheochromocytoma N Engl J Med 2007 357 306-308 
Stratakis CA Carney JA The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney&#8211;Stratakis syndrome): molecular genetics and clinical implications J Intern Med 2009 266 43-52 
Launonen V Vierimaa O Kiuru M Isola J Roth S Pukkala E Sistonen P Herva R Aaltonen LA Inherited susceptibility to uterine leiomyomas and renal cell cancer Proc Natl Acad Sci USA 2001 98 3387-3392 
Tomlinson IP Alam NA Rowan AJ Barclay E Jaeger EE Kelsell D Leigh I Gorman P Lamlum H Rahman S Roylance RR Olpin S Bevan S Barker K Hearle N Houlston RS Kiuru M Lehtonen R Karhu A Vilkki S Laiho P Eklund C Vierimaa O Aittomaki K Hietala M Sistonen P Paetau A Salovaara R Herva R Launonen V Aaltonen LA Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat Genet 2002 30 406-410 
Carvajal-Carmona LG Alam NA Pollard PJ Jones AM Barclay E Wortham N Pignatelli M Freeman A Pomplun S Ellis I Poulsom R El-Bahrawy MA Berney DM Tomlinson IP Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations J Clin Endocrinol Metab 2006 91 3071-3075 
Lehtonen HJ Kiuru M Ylisaukko-Oja SK Salovaara R Herva R Koivisto PA Vierimaa O Aittomaki K Pukkala E Launonen V Aaltonen LA Increased risk of cancer in patients with fumarate hydratase germline mutation J Med Genet 2006 43 523-526 
Marcucci G Maharry K Wu YZ Radmacher MD Mrozek K Margeson D Holland KB Whitman SP Becker H Schwind S Metzeler KH Powell BL Carter TH Kolitz JE Wetzler M Carroll AJ Baer MR Caligiuri MA Larson RA Bloomfield CD IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study J Clin Oncol 2010 28 2348-2355 
Balss J Meyer J Mueller W Korshunov A Hartmann C Deimling A Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol 2008 116 597-602 
Parsons DW Jones S Zhang X Lin JC Leary RJ Angenendt P Mankoo P Carter H Siu IM Gallia GL Olivi A McLendon R Rasheed BA Keir S Nikolskaya T Nikolsky Y Busam DA Tekleab H Diaz LA Jr Hartigan J Smith DR Strausberg RL Marie SK Shinjo SM Yan H Riggins GJ Bigner DD Karchin R Papadopoulos N Parmigiani G Vogelstein B Velculescu VE Kinzler KW An integrated genomic analysis of human glioblastoma multiforme Science 2008 321 1807-1812 
Bleeker FE Lamba S Leenstra S Troost D Hulsebos T Vandertop WP Frattini M Molinari F Knowles M Cerrato A Rodolfo M Scarpa A Felicioni L Buttitta F Malatesta S Marchetti A Bardelli A IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors Hum Mutat 2009 30 7-11 
Yan H Parsons DW Jin G McLendon R Rasheed BA Yuan W Kos I Batinic-Haberle I Jones S Riggins GJ Friedman H Friedman A Reardon D Herndon J Kinzler KW Velculescu VE Vogelstein B Bigner DD IDH1 and IDH2 mutations in gliomas N Engl J Med 2009 360 765-773 
Dang L White DW Gross S Bennett BD Bittinger MA Driggers EM Fantin VR Jang HG Jin S Keenan MC Marks KM Prins RM Ward PS Yen KE Liau LM Rabinowitz JD Cantley LC Thompson CB Vander Heiden MG Su SM Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 2009 462 739-744 
Gimenez-Roqueplo AP Favier J Rustin P Mourad JJ Plouin PF Corvol P Rotig A Jeunemaitre X The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway Am J Hum Genet 2001 69 1186-1197 
Dahia PL Ross KN Wright ME Hayashida CY Santagata S Barontini M Kung AL Sanso G Powers JF Tischler AS Hodin R Heitritter S Moore F Dluhy R Sosa JA Ocal IT Benn DE Marsh DJ Robinson BG Schneider K Garber J Arum SM Korbonits M Grossman A Pigny P Toledo SP Nose V Li C Stiles CD A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas PLoS Genet 2005 1 72-80 
Vanharanta S Pollard PJ Lehtonen HJ Laiho P Sjoberg J Leminen A Aittomaki K Arola J Kruhoffer M Orntoft TF Tomlinson IP Kiuru M Arango D Aaltonen LA Distinct expression profile in fumarate-hydratase-deficient uterine fibroids Hum Mol Genet 2006 15 97-103 
Cervera AM Apostolova N Crespo FL Mata M McCreath KJ Cells silenced for SDHB expression display characteristic features of the tumor phenotype Cancer Res 2008 68 4058-4067 
Ashrafian H O'Flaherty L Adam J Steeples V Chung YL East P Vanharanta S Lehtonen H Nye E Hatipoglu E Miranda M Howarth K Shukla D Troy H Griffiths J Spencer-Dene B Yusuf M Volpi E Maxwell PH Stamp G Poulsom R Pugh CW Costa B Bardella C Renzo MF Kotlikoff MI Launonen V Aaltonen L El-Bahrawy M Tomlinson I Pollard PJ Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis Cancer Res 2010 70 9153-9165 
Selak MA Armour SM MacKenzie ED Boulahbel H Watson DG Mansfield KD Pan Y Simon MC Thompson CB Gottlieb E Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 2005 7 77-85 
Isaacs JS Jung YJ Mole DR Lee S Torres-Cabala C Chung YL Merino M Trepel J Zbar B Toro J Ratcliffe PJ Linehan WM Neckers L HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 2005 8 143-153 
Pollard PJ Briere JJ Alam NA Barwell J Barclay E Wortham NC Hunt T Mitchell M Olpin S Moat SJ Hargreaves IP Heales SJ Chung YL Griffiths JR Dalgleish A McGrath JA Gleeson MJ Hodgson SV Poulsom R Rustin P Tomlinson IP Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations Hum Mol Genet 2005 14 2231-2239 
Hewitson KS Lienard BM McDonough MA Clifton IJ Butler D Soares AS Oldham NJ McNeill LA Schofield CJ Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates J Biol Chem 2007 282 3293-3301 
MacKenzie ED Selak MA Tennant DA Payne LJ Crosby S Frederiksen CM Watson DG Gottlieb E Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells Mol Cell Biol 2007 27 3282-3289 
Porcelli AM Ghelli A Ceccarelli C Lang M Cenacchi G Capristo M Pennisi LF Morra I Ciccarelli E Melcarne A Bartoletti-Stella A Salfi N Tallini G Martinuzzi A Carelli V Attimonelli M Rugolo M Romeo G Gasparre G The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization Hum Mol Genet 2010 19 1019-1032 
Guzy RD Hoyos B Robin E Chen H Liu L Mansfield KD Simon MC Hammerling U Schumacker PT Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing Cell Metab 2005 1 401-408 
Mansfield KD Guzy RD Pan Y Young RM Cash TP Schumacker PT Simon MC Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation Cell Metab 2005 1 393-399 
Guzy RD Sharma B Bell E Chandel NS Schumacker PT Loss of the SdhB, but not the SdhA, subunit of complex II triggers ROS-dependent HIF activation and tumorigenesis Mol Cell Biol 2008 28 718-731 
Sudarshan S Sourbier C Kong HS Block K Valera Romero VA Yang Y Galindo C Mollapour M Scroggins B Goode N Lee MJ Gourlay CW Trepel J Linehan WM Neckers L Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species Mol Cell Biol 2009 29 4080-4090 
Selak MA Duran RV Gottlieb E Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells Biochim Biophys Acta 2006 1757 567-572 
O'Flaherty L Adam J Heather LC Zhdanov AV Chung YL Miranda MX Croft J Olpin S Clarke K Pugh CW Griffiths J Papkovsky D Ashrafian H Ratcliffe PJ Pollard PJ Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism Hum Mol Genet 2010 19 3844-3851 
Lee S Nakamura E Yang H Wei W Linggi MS Sajan MP Farese RV Freeman RS Carter BD Kaelin WG Jr Schlisio S Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer Cancer Cell 2005 8 155-167 
Schlisio S Kenchappa RS Vredeveld LC George RE Stewart R Greulich H Shahriari K Nguyen NV Pigny P Dahia PL Pomeroy SL Maris JM Look AT Meyerson M Peeper DS Carter BD Kaelin WG Jr The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor Genes Dev 2008 22 884-893 
Raimundo N Vanharanta S Aaltonen LA Hovatta I Suomalainen A Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas Oncogene 2009 28 1261-1273 
Schofield CJ Ratcliffe PJ Oxygen sensing by HIF hydroxylases Nat Rev Mol Cell Biol 2004 5 343-354 
Cervera AM Bayley JP Devilee P McCreath KJ Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells Mol Cancer 2009 8 89 
Smith EH Janknecht R Maher LJ 3rd Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma Hum Mol Genet 2007 16 3136-3148 
Teperino R Schoonjans K Auwerx J Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab 2010 12 321-327 
Pollard PJ Loenarz C Mole DR McDonough MA Gleadle JM Schofield CJ Ratcliffe PJ Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha Biochem J 2008 416 387-394 
Beyer S Kristensen MM Jensen KS Johansen JV Staller P The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF J Biol Chem 2008 283 36542-36552 
Yang J Jubb AM Pike L Buffa FM Turley H Baban D Leek R Gatter KC Ragoussis J Harris AL The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth Cancer Res 2010 70 6456-6466 
He W Miao FJ Lin DC Schwandner RT Wang Z Gao J Chen JL Tian H Ling L Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors Nature 2004 429 188-193 
Peti-Peterdi J High glucose and renin release: the role of succinate and GPR91 Kidney Int 2010 78 1214-1217 
Sapieha P Sirinyan M Hamel D Zaniolo K Joyal JS Cho JH Honore JC Kermorvant-Duchemin E Varma DR Tremblay S Leduc M Rihakova L Hardy P Klein WH Mu X Mamer O Lachapelle P Polo A Beausejour C Andelfinger G Mitchell G Sennlaub F Chemtob S The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis Nat Med 2008 14 1067-1076 
Tian Z Liu Y Usa K Mladinov D Fang Y Ding X Greene AS Cowley AW Jr Liang M Novel role of fumarate metabolism in dahl-salt sensitive hypertension Hypertension 2009 54 255-260 
Mardis ER Ding L Dooling DJ Larson DE McLellan MD Chen K Koboldt DC Fulton RS Delehaunty KD McGrath SD Fulton LA Locke DP Magrini VJ Abbott RM Vickery TL Reed JS Robinson JS Wylie T Smith SM Carmichael L Eldred JM Harris CC Walker J Peck JB Du F Dukes AF Sanderson GE Brummett AM Clark E McMichael JF Meyer RJ Schindler JK Pohl CS Wallis JW Shi X Lin L Schmidt H Tang Y Haipek C Wiechert ME Ivy JV Kalicki J Elliott G Ries RE Payton JE Westervelt P Tomasson MH Watson MA Baty J Heath S Shannon WD Nagarajan R Link DC Walter MJ Graubert TA DiPersio JF Wilson RK Ley TJ Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 2009 361 1058-1066 
Gross S Cairns RA Minden MD Driggers EM Bittinger MA Jang HG Sasaki M Jin S Schenkein DP Su SM Dang L Fantin VR Mak TW Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations J Exp Med 2010 207 339-344 
Ward PS Patel J Wise DR Abdel-Wahab O Bennett BD Coller HA Cross JR Fantin VR Hedvat CV Perl AE Rabinowitz JD Carroll M Su SM Sharp KA Levine RL Thompson CB The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 2010 17 225-234 
Zhao S Lin Y Xu W Jiang W Zha Z Wang P Yu W Li Z Gong L Peng Y Ding J Lei Q Guan KL Xiong Y Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 2009 324 261-265 
Pollard PJ Ratcliffe PJ Cancer. Puzzling patterns of predisposition Science 2009 324 192-194 
Figueroa ME Abdel-Wahab O Lu C Ward PS Patel J Shih A Li Y Bhagwat N Vasanthakumar A Fernandez HF Tallman MS Sun Z Wolniak K Peeters JK Liu W Choe SE Fantin VR Paietta E Lowenberg B Licht JD Godley LA Delwel R Valk PJ Thompson CB Levine RL Melnick A Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 2010 18 553-567 
Jorgensen G Kohlberg and Gilligan: duet or duel? J Moral Educ 2006 5 179-196 
Kohlberg L Moral stages and moralisation. The cognitive-developmental approach Lickona T Moral Development and Behaviour: Theory, Research and Social issues New York Holt, Rinehart and Winston 1976 31-53 
Kohlberg L The Psychology of Moral Development. The Nature and Validity of Moral Stages San Francisco, CA Harper &amp; Row 1984 
Arnold ML Stage, sequence, and sequels: changing conceptions of morality, post-Kohlberg Educ Psychol Rev 2000 12 365-383 
Gilligan C In a Different Voice: Psychological Theory and Women&#8217;s Development Cambridge, MA, and London Harvard University Press 1993 
Branch WT Jr Supporting the moral development of medical students J Gen Int Med 2000 15 503-508 
Turiel E Thoughts, emotions and social interactional processes in moral development Killen M , Smetana JG Handbook of Moral Development Mahway, NJ Taylor and Francis e-Library 
Rest J Narvaez D Bebeau MJ Thoma SJ Post-Conventional Moral Thinking. A Neo-Kohlbergian Approach Mahwah, NJ Lawrence Erlbaum 
Skisland A Bj&#248;rnestad JO S&#246;derhamn O Construction and testing of The Moral Development Scale for Professionals (MDSP) Nurse Educ Today 2011 In press.
Kohlberg L Power C Moral development, religious thinking, and the question of a seventh stage Zygon 1981 16 203-259 
Streiner DL Norman GR Health Measurement Scales: A Practical Guide to Their Development and Use 3rd ed Oxford Oxford University Press 2003 
J&#246;reskog KG Estimating and testing of simplex models British Journal of Mathematics and Statistical Psychology 1979 23 121-145 
Muth&#233;n LK Muth&#233;n BO Mplus: The Comprehensive Modelling Program for Applied Researchers. User&#8217;s Guide 3rd ed Los Angeles, CA Muth&#233;n &amp; Muth&#233;n 2004 
Gustafsson J-E Stahl PA STREAMS User&#8217;s Guide, Version 3.0.0 M&#246;lndal MultivariateWare HB 2005 
Brown MW Cudeck R Alternative ways of assessing model fit Bollen KA , Long JS Testing Structural Equation Models Newbury Park, CA Sage 1993 136-162 
Cronbach LJ Coefficient alpha and the internal structure of tests Psykometrika 1951 16 297-334 
Beauchamp TL Childress JF Principles of Biomedical Ethics 6th ed Oxford Oxford University Press 2009 
Ethical principles for medical research involving human subjects Tokyo World Medical Association Declaration of Helsinki 2008 
Dawson TL New tools, new insights: Kohlberg&#8217;s moral judgement stages revisited International Journal of Behavioural Development 2002 26 154-166 
Rest JR DIT. Defining Issues Test University of Minnesota, Minneapolis.
Auvinen J Suominen T Leino-Kilpi H Helkama K The development of moral judgement during nursing education in Finland Nurse Educ Today 2004 24 538-546 
Aboujaoude E Barry JJ Gamel N Memantine augmentation in treatment-resistant obsessive&#8211;compulsive disorder: an open-label trial J Clin Psychopharmacol 2009 29 51-55 
Abramowitz JS Taylor S McKay D Obsessive&#8211;compulsive disorder Lancet 2009 374 491-499 
Amiel JM Mathew SJ Glutamate and anxiety disorders Curr Psychiatry Rep 2007 9 278-283 
Anthony EW Nevins ME Anxiolytic-like effects of N-methyl- Eur J Pharmacol 1993 250 317-324 
Boyce-Rustay JM Holmes A Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice Neuropsychopharmacology 2006 31 2405-2414 
Campeau S Miserendino MJ Davis M Intra-amygdala infusion of the N-methyl- Behav Neurosci 1992 106 569-574 
Coric V Taskiran S Pittenger C Wasylink S Mathalon DH Valentine G Saksa J Wu YT Gueorguieva R Sanacora G Malison RT Krystal JH Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial Biol Psychiatry 2005 58 424-428 
Dunn RW Corbett R Fielding S Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze Eur J Pharmacol 1989 169 1-10 
Emmett MR Mick SJ Cler JA Rao TS Iyengar S Wood PL Actions of Neuropharmacology 1991 30 1167-1171 
Fendt M Koch M Schnitzler HU NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response Eur J Pharmacol 1996 318 1-6 
Feusner JD Kerwin L Saxena S Bystritsky A Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial Psychopharmacol Bull 2009 42 81-93 
Heresco-Levy U Kremer I Javitt DC Goichman R Reshef A Blanaru M Cohen T Pilot-controlled trial of Int J Neuropsychopharmacol 2002 5 301-307 
Ho YJ Hsu LS Wang CF Hsu WY Lai TJ Hsu CC Tsai YF Behavioral effects of Brain Res 2005 1043 179-185 
Hood WF Compton RP Monahan JB Neurosci Lett 1989 98 91-95 
Johnson JW Ascher P Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 1987 325 529-531 
Kalueff A Nutt DJ Role of GABA in memory and anxiety Depress Anxiety 1996 4 100-110 
Karcz-Kubicha M Jessa M Nazar M Pla&#378;nik A Hartmann S Parsons CG Danysz W Anxiolytic activity of glycine-B antagonists and partial agonists&#8211;no relation to intrinsic activity in the patch clamp Neuropharmacology 1997 36 1355-1367 
Kessler M Terramani T Lynch G Baudry M A glycine site associated with N-methyl- J Neurochem 1989 52 1319-1328 
Kew JN Kemp JA Ionotropic and metabotropic glutamate receptor structure and pharmacology Psychopharmacology (Berl) 2005 179 4-29 
Kleckner NW Dingledine R Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes Science 1988 241 835-837 
Kleckner NW Dingledine R Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl- Mol Pharmacol 1989 36 430-436 
K&#322;odzi&#324;ska A Chojnacka-W&#243;jcik E Anticonflict effect of the glycineB receptor partial agonist, Psychopharmacology (Berl) 2000 152 224-228 
Kotli&#324;ska J Liljequist S A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701, 324 Psychopharmacology (Berl) 1998 135 175-181 
Krystal JH D&#8217;Souza DC Petrakis IL Belger A Berman RM Charney DS Abi-Saab W Madonick S NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders Harv Rev Psychiatry 1999 7 125-143 
Lipman JJ Spencer PS Rapid intracerebroventricular injection assisted by an automatic syringe J Pharmacol Methods 1980 4 327-333 
Lister RG The use of a plus-maze to measure anxiety in the mouse Psychopharmacology (Berl) 1987 92 180-185 
Lydiard RB The role of GABA in anxiety disorders J Clin Psychiatry 2003 64 Suppl 3 21-27 
Mathew SJ Amiel JM Coplan JD Fitterling HA Sackeim HA Gorman JM Open-label trial of riluzole in generalized anxiety disorder Am J Psychiatry 2005 162 2379-2381 
Nemeroff CB The role of GABA in the pathophysiology and treatment of anxiety disorders Psychopharmacol Bull 2003 37 133-146 
Nutt DJ Malizia AL New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder Br J Psychiatry 2001 179 390-396 
Parsons CG Danysz W Quack G Glutamate in CNS disorders as a target for drug development: an update Drug News Perspect 1998 11 523-569 
Pellow S Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp Clin Pharmacol 1986 8 557-565 
Pellow S Chopin P File SE Briley M Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 1985 14 149-167 
P&#322;a&#378;nik A Pa&#322;ejko W Nazar M Jessa M Effects of antagonists at the NMDA receptor complex in two models of anxiety Eur Neuropsychopharmacol 1994 4 503-512 
Poleszak E Szewczyk B K&#281;dzierska E Wla&#378; P Pilc A Nowak G Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacol Biochem Behav 2004 78 7-12 
Poleszak E Wla&#378; P Wr&#243;bel A Fidecka S Nowak G NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice Pharmacol Rep 2008 60 655-663 
Przegali&#324;ski E Tatarczy&#324;ska E Chojnacka-W&#243;jcik E Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors Pol J Pharmacol 1998 50 349-354 
Przegali&#324;ski E Tatarczy&#324;ska E Chojnacka-W&#243;jcik E The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats Neuropharmacology 2000 39 1858-1864 
Ressler KJ Rothbaum BO Tannenbaum L Anderson P Graap K Zimand E Hodges L Davis M Cognitive enhancers as adjuncts to psychotherapy: use of Arch Gen Psychiatry 2004 61 1136-1144 
Sharma AC Kulkarni SK Evidence for benzodiazepine receptor interaction with MK 801 in anxiety related behaviour in rats Indian J Exp Biol 1993 31 191-193 
Sieghart W Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes Pharmacol Rev 1995 47 181-234 
Sieghart W Fuchs K Tretter V Ebert V Jechlinger M Hoger H Adamiker D Structure and subunit composition of GABAA receptors Neurochem Int 1999 34 379-385 
Stahl SM Don&#8217;t ask, don&#8217;t tell, but benzodiazepines are still the leading treatments for anxiety disorder J Clin Psychiatry 2002 63 756-757 
Tricklebank MD Singh L Oles RJ Preston C Iversen SD The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor Eur J Pharmacol 1989 167 127-135 
Trullas R Jackson B Skolnick P Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors Pharmacol Biochem Behav 1989 34 313-316 
Trullas R Folio T Young A Miller R Boje K Skolnick P Eur J Pharmacol 1991 203 379-385 
Uhlenhuth EH Balter MB Ban TA Yang K International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders J Clin Psychopharmacol 1999 19 23S-29S 
Watson GB Bolanowski MA Baganoff MP Deppeler CL Lanthorn TH Brain Res 1990 510 158-160 
Willetts J Balster RL Leander JD The behavioral pharmacology of NMDA receptor antagonists Trends Pharmacol Sci 1990 11 423-428 
Wood PL Emmett MR Rao TS Mick S Cler J Iyengar S In vivo modulation of the N-methyl- J Neurochem 1989 53 979-981 
Wood PL Hawkinson JE Goodnough DB Formation of J Neurochem 1996 67 1485-1490 
